IWC
HUMA icon

Integrated Wealth Concepts’s Humacyte HUMA Stock Holding History

Integrated Wealth Concepts’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08K Sell
10,348
-5,884
-36% -$5.45K ﹤0.01% 4691
2026
Q1 		$9.85K Buy
+16,232
New +$16.9K ﹤0.01% 2270

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Integrated Wealth Concepts's HUMA Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its Humacyte (HUMA) stake by 36% in Q2 2026, selling an estimated $5.45K and leaving 10,348 shares worth $8.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4691.

Integrated Wealth Concepts first reported a position in HUMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.85K in Q1 2026. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Integrated Wealth Concepts held 10,348 shares of Humacyte worth $8.08K as of Q2 2026.
  • Integrated Wealth Concepts sold 5,884 Humacyte shares in Q2 2026, an estimated $5.45K.
  • Humacyte made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4691 holding.
  • Integrated Wealth Concepts first reported a position in Humacyte in Q1 2026 and has held it in 2 quarters since.
  • Integrated Wealth Concepts's Humacyte position peaked at $9.85K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.